These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18699977)

  • 21. Individualized acute treatment strategies for gastroesophageal reflux disease.
    Reynolds JC
    Scand J Gastroenterol Suppl; 1995; 213():17-24. PubMed ID: 8578239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical treatments of GERD: the old and new.
    Vela MF
    Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
    Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
    Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease.
    Dellon ES; Shaheen NJ
    Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical therapy of reflux laryngitis.
    Johnson DA
    J Clin Gastroenterol; 2008; 42(5):589-93. PubMed ID: 18427287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
    Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
    Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current indications for cisapride].
    Arch Pediatr; 2001 Apr; 8(4):352-4. PubMed ID: 11339124
    [No Abstract]   [Full Text] [Related]  

  • 30. Comments on a prospective study into using prokinetics with proton pump inhibitors.
    Langstaff L
    J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):152. PubMed ID: 22569017
    [No Abstract]   [Full Text] [Related]  

  • 31. Virtue of adding prokinetics to proton pump inhibitors in the treatment of laryngopharyngeal reflux disease: prospective study.
    Ezzat WF; Fawaz SA; Fathey H; El Demerdash A
    J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):350-6. PubMed ID: 21777555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.
    Tolman KG; Chandramouli J; Fang JC
    Expert Opin Pharmacother; 2000 Sep; 1(6):1171-94. PubMed ID: 11249486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroesophageal reflux in children with cerebral palsy: efficacy of cisapride.
    Bozkurt M; Tutuncuoglu S; Serdaroglu G; Tekgul H; Aydogdu S
    J Child Neurol; 2004 Dec; 19(12):973-6. PubMed ID: 15704873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In patients with typical symptoms of GERD and without alarm symptoms, what are the most appropriate dose and duration of empirical PPI therapy that would allow a definitive diagnosis of GERD?].
    Ponce M
    Gastroenterol Hepatol; 2009 Feb; 32(2):126-7. PubMed ID: 19231690
    [No Abstract]   [Full Text] [Related]  

  • 35. Weakly acidic reflux.
    Tack J; Blondeau K
    Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mosapride for gastroesophageal reflux disease in neurologically impaired patients.
    Komura M; Kanamori Y; Tanaka Y; Kodaka T; Sugiyama M; Terawaki K; Suzuki K; Iwanaka T
    Pediatr Int; 2017 Mar; 59(3):347-351. PubMed ID: 27561215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non response to proton pump inhibitors in gastroesophageal reflux disease].
    Lochner S; Kirch W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1956. PubMed ID: 19760560
    [No Abstract]   [Full Text] [Related]  

  • 39. [QTc interval in newborns with gastroesophageal reflux treated with cisapride and ranitidine].
    Lista G; Maestri L; Meroni M; Massari D; Colli A; Porcelli F; Menchini M; Introvini P; Compagnoni G
    Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():633-6. PubMed ID: 11424819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative study of therapy effects between esomeprazole plus mosapride citrate and botulinum toxin injection on vocal process granuloma].
    Lei L; Yang H; Zhao Y; Zhang XS; Zou J; Ren J; Zheng YT; Ren JJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(13):1006-1009. PubMed ID: 29798164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.